dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cicala, Carlo Maria |
dc.contributor.author | Musacchio, lucia |
dc.contributor.author | Scambia, Giovanni |
dc.contributor.author | Lorusso, Domenica |
dc.date.accessioned | 2023-06-28T07:27:41Z |
dc.date.available | 2023-06-28T07:27:41Z |
dc.date.issued | 2023 |
dc.identifier.citation | Cicala CM, Musacchio L, Scambia G, Lorusso D. Dostarlimab: From preclinical investigation to drug approval and future directions. Hum Vaccin Immunother. 2023;19(1):2178220. |
dc.identifier.issn | 2164-554X |
dc.identifier.uri | https://hdl.handle.net/11351/9914 |
dc.description | Càncer d'endometri; Immunoteràpia; Càncer de recte |
dc.language.iso | eng |
dc.publisher | Taylor & Francis |
dc.relation.ispartofseries | Human Vaccines & Immunotherapeutics;19(1) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Anticossos monoclonals - Ús terapèutic |
dc.subject | Medicaments - Desenvolupament |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | Antibodies, Monoclonal |
dc.subject.mesh | Drug Approval |
dc.title | Dostarlimab: From preclinical investigation to drug approval and future directions |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1080/21645515.2023.2178220 |
dc.subject.decs | neoplasias |
dc.subject.decs | anticuerpos monoclonales |
dc.subject.decs | autorización de medicamentos |
dc.relation.publishversion | https://doi.org/10.1080/21645515.2023.2178220 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Cicala CM] Department of Medical and Surgical Science, Medical Oncology Unit, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Sarcoma Translational Research Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Musacchio L] Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. [Scambia G, Lorusso D] Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, Rome, Italy |
dc.identifier.pmid | 36762991 |
dc.identifier.wos | 000932078300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |